SLS Annual Operating Expenses
$37.87 M
+$5.02 M+15.28%
31 December 2023
Summary:
As of January 20, 2025, SLS annual total operating expenses is $37.87 million, with the most recent change of +$5.02 million (+15.28%) on December 31, 2023. During the last 3 years, it has risen by +$18.99 million (+100.56%). SLS annual operating expenses is now -13.74% below its all-time high of $43.90 million, reached on December 31, 2014.SLS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLS Quarterly Operating Expenses
$7.33 M
-$292.00 K-3.83%
30 September 2024
Summary:
As of January 20, 2025, SLS quarterly total operating expenses is $7.33 million, with the most recent change of -$292.00 thousand (-3.83%) on September 30, 2024. Over the past year, it has dropped by -$848.00 thousand (-10.37%). SLS quarterly operating expenses is now -58.75% below its all-time high of $17.77 million, reached on June 30, 2014.SLS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLS Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.3% | -10.4% |
| 3 y3 years | +100.6% | -19.0% |
| 5 y5 years | +75.8% | -19.0% |
SLS Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +40.3% | -58.4% | +1422.9% |
| 5 y | 5-year | at high | +120.1% | -58.4% | +1422.9% |
| alltime | all time | -13.7% | +1474.6% | -58.8% | +183.8% |
SELLAS Life Sciences Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.33 M(-3.8%) |
| June 2024 | - | $7.62 M(-21.0%) |
| Mar 2024 | - | $9.64 M(+18.0%) |
| Dec 2023 | $37.87 M(+15.3%) | $8.18 M(-12.6%) |
| Sept 2023 | - | $9.36 M(+3.4%) |
| June 2023 | - | $9.05 M(-19.8%) |
| Mar 2023 | - | $11.28 M(-2136.3%) |
| Dec 2022 | $32.85 M(+21.7%) | -$554.00 K(-107.8%) |
| Sept 2022 | - | $7.15 M(-17.1%) |
| June 2022 | - | $8.62 M(-51.1%) |
| Mar 2022 | - | $17.64 M(+197.9%) |
| Dec 2021 | $26.99 M(+43.0%) | $5.92 M(-15.2%) |
| Sept 2021 | - | $6.98 M(+11.6%) |
| June 2021 | - | $6.25 M(-20.3%) |
| Mar 2021 | - | $7.84 M(+29.5%) |
| Dec 2020 | $18.88 M(+9.7%) | $6.06 M(+34.9%) |
| Sept 2020 | - | $4.49 M(+5.3%) |
| June 2020 | - | $4.27 M(+5.0%) |
| Mar 2020 | - | $4.06 M(-12.5%) |
| Dec 2019 | $17.21 M(-20.1%) | $4.65 M(+11.0%) |
| Sept 2019 | - | $4.18 M(+4.1%) |
| June 2019 | - | $4.02 M(-7.8%) |
| Mar 2019 | - | $4.36 M(-30.7%) |
| Dec 2018 | $21.54 M(+1.8%) | $6.29 M(+105.6%) |
| Sept 2018 | - | $3.06 M(-52.9%) |
| June 2018 | - | $6.50 M(+14.4%) |
| Mar 2018 | - | $5.68 M(-15.1%) |
| Dec 2017 | $21.16 M(+32.3%) | $6.70 M(+50.0%) |
| Sept 2017 | - | $4.46 M(-21.3%) |
| June 2017 | - | $5.67 M(+26.8%) |
| Mar 2017 | - | $4.47 M(-151.1%) |
| Dec 2016 | $15.99 M(-53.3%) | -$8.74 M(-235.1%) |
| Sept 2016 | - | $6.47 M(-30.3%) |
| June 2016 | - | $9.29 M(+3.6%) |
| Mar 2016 | - | $8.97 M(+18.2%) |
| Dec 2015 | $34.22 M | $7.59 M(-12.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2015 | - | $8.63 M(-4.9%) |
| June 2015 | - | $9.08 M(+1.9%) |
| Mar 2015 | - | $8.91 M(-8.1%) |
| Dec 2014 | $43.90 M(+54.1%) | $9.69 M(-8.3%) |
| Sept 2014 | - | $10.57 M(-40.5%) |
| June 2014 | - | $17.77 M(+29.8%) |
| Mar 2014 | - | $13.69 M(+124.9%) |
| Dec 2013 | $28.49 M(+34.4%) | $6.09 M(-22.0%) |
| Sept 2013 | - | $7.80 M(-2.3%) |
| June 2013 | - | $7.99 M(+20.8%) |
| Mar 2013 | - | $6.61 M(+18.5%) |
| Dec 2012 | $21.20 M(+69.8%) | $5.58 M(+0.9%) |
| Sept 2012 | - | $5.53 M(-2.7%) |
| June 2012 | - | $5.68 M(+28.9%) |
| Mar 2012 | - | $4.41 M(+22.7%) |
| Dec 2011 | $12.49 M(-24.9%) | $3.59 M(+4.6%) |
| Sept 2011 | - | $3.44 M(+50.8%) |
| June 2011 | - | $2.28 M(-56.8%) |
| Mar 2011 | - | $5.28 M(+42.7%) |
| Dec 2010 | $16.63 M(-5.1%) | $3.70 M(-0.6%) |
| Sept 2010 | - | $3.72 M(-21.8%) |
| June 2010 | - | $4.75 M(+6.7%) |
| Mar 2010 | - | $4.46 M(+3.8%) |
| Dec 2009 | $17.52 M(+20.4%) | $4.29 M(+7.8%) |
| Sept 2009 | - | $3.98 M(-21.5%) |
| June 2009 | - | $5.08 M(+21.7%) |
| Mar 2009 | - | $4.17 M(+3.5%) |
| Dec 2008 | $14.55 M(+27.2%) | $4.03 M(+16.3%) |
| Sept 2008 | - | $3.46 M(-20.3%) |
| June 2008 | - | $4.35 M(+60.2%) |
| Mar 2008 | - | $2.71 M(-2.0%) |
| Dec 2007 | $11.44 M(+375.6%) | $2.77 M(-4.3%) |
| Sept 2007 | - | $2.89 M(-40.9%) |
| June 2007 | - | $4.89 M(+246.5%) |
| Mar 2007 | - | $1.41 M(+84.3%) |
| Dec 2006 | $2.40 M | $766.00 K |
FAQ
- What is SELLAS Life Sciences annual total operating expenses?
- What is the all time high annual operating expenses for SELLAS Life Sciences?
- What is SELLAS Life Sciences annual operating expenses year-on-year change?
- What is SELLAS Life Sciences quarterly total operating expenses?
- What is the all time high quarterly operating expenses for SELLAS Life Sciences?
- What is SELLAS Life Sciences quarterly operating expenses year-on-year change?
What is SELLAS Life Sciences annual total operating expenses?
The current annual operating expenses of SLS is $37.87 M
What is the all time high annual operating expenses for SELLAS Life Sciences?
SELLAS Life Sciences all-time high annual total operating expenses is $43.90 M
What is SELLAS Life Sciences annual operating expenses year-on-year change?
Over the past year, SLS annual total operating expenses has changed by +$5.02 M (+15.28%)
What is SELLAS Life Sciences quarterly total operating expenses?
The current quarterly operating expenses of SLS is $7.33 M
What is the all time high quarterly operating expenses for SELLAS Life Sciences?
SELLAS Life Sciences all-time high quarterly total operating expenses is $17.77 M
What is SELLAS Life Sciences quarterly operating expenses year-on-year change?
Over the past year, SLS quarterly total operating expenses has changed by -$848.00 K (-10.37%)